Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Medicine (Baltimore) ; 101(27): e29849, 2022 Jul 08.
Article in English | MEDLINE | ID: mdl-35801740

ABSTRACT

BACKGROUND: This study aimed to explore the effect of high-quality nursing care (HQNC) on psychological disorder in patients with ovarian cancer (OC) during the perioperative period (PPP). METHODS: A literature search was performed at the Cochrane Library, PUBMED, Excerpt Medica Database, China National Knowledge Infrastructure, and Chinese Biomedical Literature Database from their inception until March 1, 2022. Two authors independently performed study selection, data collection, and methodological quality evaluation. The outcomes were anxiety (as measured by the Self-rating Anxiety Scale), depression (as measured by Self-rating Depression Scale), length of hospital stay, and rate of patient satisfaction. RESULTS: Eight trials involving 742 patients with OC were included in this study. Results of the data analysis showed that patients who received HQNC had a more promising effect on anxiety relief (mean difference, -9.00; random 95% confidence interval, -11.36 to -6.63; P < .001) and depression decrease (mean difference, -7.62; random 95% confidence intervals, -8.45 to -6.78; P < .001) than patients who underwent routine nursing care. CONCLUSION: This study summarized the latest evidence of HQNC on psychological disorder relief in patients with OC during perioperative period. These findings showed that HQNC may benefit patients with anxiety and depression.


Subject(s)
Mental Disorders , Ovarian Neoplasms , Anxiety , Carcinoma, Ovarian Epithelial , China , Depression/etiology , Female , Humans , Ovarian Neoplasms/complications , Ovarian Neoplasms/surgery , Quality of Life
2.
Heart Lung ; 50(1): 71-74, 2021.
Article in English | MEDLINE | ID: mdl-32711895

ABSTRACT

BACKGROUND: There is no satisfactory answer on the specific biomarker that might be used in differentiating heart failure with reduced EF (HFrEF), allowing for inadequacy of N-terminal prohormone brain natriuretic peptide (NT-proBNP). OBJECTIVES: We aim to evaluate the value of microRNA-208a in diagnosing HFrEF patients. METHODS: We included 120 HF patients and 60 healthy volunteers. Diagnostic values of NT-proBNP and miR-208a for HF patients versus controls and HFrEF versus HFpEF were described by area under curve (AUC), sensitivity and specificity. RESULTS: HFrEF patients had significantly higher miR-208a level (p<0.001). As for diagnosing HFrEF patients, additional use of miR-208a and NT-proBNP yielded a significantly higher AUC than NT-proBNP alone (0.83, 95% CI 0.76-0.90 vs. 0.73, 95% CI 0.64-0.82) and the sensitivity and specificity were raised to 68.0% and 90.2%. CONCLUSION: Use of miR-208a in combination with NT-proBNP may allow a more reliable method in diagnosing HFrEF patients.


Subject(s)
Circulating MicroRNA/blood , Heart Failure , MicroRNAs/blood , Biomarkers , Heart Failure/diagnosis , Humans , Natriuretic Peptide, Brain , Peptide Fragments , Stroke Volume
SELECTION OF CITATIONS
SEARCH DETAIL
...